Viva Biotech Holdings (HKG:1873)
Hong Kong · Delayed Price · Currency is HKD 1.560
+0.020 (1.30%)
May 7, 2026, 4:08 PM HKT
Viva Biotech Holdings Market Cap
Viva Biotech Holdings has a market cap or net worth of 3.25 billion as of May 7, 2026. Its market cap has increased by 13.23% in one year.
Market Cap
3.25B
Enterprise Value
3.53B
Revenue
1.92B
Ranking
n/a
PE Ratio
15.38
Stock Price
1.56
Market Cap Chart
Since May 9, 2019, Viva Biotech Holdings's market cap has decreased from 6.63B to 3.25B, a decrease of -50.96%. That is a compound annual growth rate of -9.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 3.29B | -13.30% |
| Dec 31, 2025 | 3.80B | 109.02% |
| Dec 31, 2024 | 1.82B | -19.19% |
| Dec 29, 2023 | 2.25B | -32.91% |
| Dec 30, 2022 | 3.35B | -62.94% |
| Dec 31, 2021 | 9.04B | -48.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Luzhu Biotechnology | 4.57B |
| Shandong Boan Biotechnology | 4.25B |
| Qyuns Therapeutics | 3.86B |
| BioDlink International Company | 3.81B |
| Clover Biopharmaceuticals | 3.71B |
| TYK Medicines | 3.67B |
| Mirxes Holding Company | 3.66B |
| Antengene Corporation | 3.23B |